Latest Medivir News & Updates

See the latest news and media coverage for Medivir. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Medivir

Drug discovery and development company

medivir.com
Headquarters
Huddinge, Sweden
Founded year
1988
Company type
Public company
Number of employees
2–50

Last updated

Latest news about Medivir

In short: Medivir advanced its liver cancer and bone disease pipelines while strengthening its financial position through share issues and a new CFO appointment.

Company announcements

Medivir

Medivir announces first patient enrolled in FLEX-HCC study

The randomized phase 2 study evaluates fostrox plus lenvatinib versus lenvatinib monotherapy in second-line advanced liver cancer.

Unlock all announcements with a

Media coverage

Omni

Medivir tops up the cash for drug projects

After the stock market closed, the pharmaceutical company Medivir announced plans for a directed new share issue of around 130 million kronor. This is stated in a press release.

Dagens industri

Medivir reduces the loss

The specialist pharmaceutical company Medivir reports an EBITDA result for the first quarter of -8.8 million kronor (-12.6).

Unlock all articles with a

Never miss news about Medivir

Track Medivir and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Medivir competitors & trending companies

Browse news for competitors to Medivir and other trending companies.